These observations are further substantiated by a meta-analysis of gene expression, which shows that osteoprotegerin expression in metastatic prostate tissue is increased compared to normal prostate and prostate carcinoma samples. The gene discussed is TNFRSF11B; the disease is prostate carcinoma.